Takeda Pharmaceutical (TAK) Enterprise Value (2018 - 2025)
Historic Enterprise Value for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to -$7.0 billion.
- Takeda Pharmaceutical's Enterprise Value fell 2459.02% to -$7.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$7.0 billion, marking a year-over-year decrease of 2459.02%. This contributed to the annual value of -$4.8 billion for FY2025, which is 4739.81% down from last year.
- According to the latest figures from Q4 2025, Takeda Pharmaceutical's Enterprise Value is -$7.0 billion, which was down 2459.02% from -$7.1 billion recorded in Q3 2025.
- In the past 5 years, Takeda Pharmaceutical's Enterprise Value registered a high of -$3.2 billion during Q1 2024, and its lowest value of -$11.2 billion during Q2 2021.
- Moreover, its 5-year median value for Enterprise Value was -$6.5 billion (2023), whereas its average is -$7.0 billion.
- Per our database at Business Quant, Takeda Pharmaceutical's Enterprise Value crashed by 5786.42% in 2021 and then skyrocketed by 4440.37% in 2023.
- Over the past 5 years, Takeda Pharmaceutical's Enterprise Value (Quarter) stood at -$10.5 billion in 2021, then rose by 24.37% to -$8.0 billion in 2022, then skyrocketed by 31.75% to -$5.4 billion in 2023, then decreased by 3.55% to -$5.6 billion in 2024, then fell by 24.59% to -$7.0 billion in 2025.
- Its Enterprise Value was -$7.0 billion in Q4 2025, compared to -$7.1 billion in Q3 2025 and -$5.0 billion in Q2 2025.